Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
CLGN holding history
CollPlant Biotechnologies Ltd in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLGN overviewAll 13F holders of CLGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 1
- Value
- $1
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $1 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1 | $1 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1 | $3 | <0.1% | −2,405−100.0% | Reduced | Holders |
| Q3 2025 | 2,406 | $6.47K | <0.1% | +2,405+240,500.0% | Added | Holders |
| Q2 2025 | 1 | $3 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1 | $4 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1 | $6 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1 | $8 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1 | $8 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1 | $9 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1 | $12 | <0.1% | −120−99.2% | Reduced | Holders |
| Q3 2023 | 121 | $674 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 121 | $987 | <0.1% | −50−29.2% | Reduced | Holders |
| Q1 2023 | 171 | $1.20K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 171 | $1.43K | <0.1% | −2−1.2% | Reduced | Holders |
| Q3 2022 | 173 | $1.00K | <0.1% | +123+246.0% | Added | Holders |
| Q2 2022 | 50 | $0 | 0.0% | −200−80.0% | Reduced | Holders |
| Q1 2022 | 250 | $3.00K | <0.1% | −471−65.3% | Reduced | Holders |
| Q4 2021 | 721 | $12.0K | <0.1% | +671+1,342.0% | Added | Holders |
| Q3 2021 | 50 | $1.00K | <0.1% | −100−66.7% | Reduced | Holders |
| Q2 2021 | 150 | $3.00K | <0.1% | +150 | New | Holders |